Weight-band-based simplification of oral allometric miltefosine dosing in paediatric patients with visceral leishmaniasis. [PDF]
Mazariegos Herrera A +3 more
europepmc +1 more source
Synthesis and Biological Evaluation of Imidazopyridine-Isatin Hybrids as Inhibitors of <i>Leishmania major</i> Growth. [PDF]
El Hassab MA +12 more
europepmc +1 more source
Miltefosine: a novel internal standard approach to lysophospholipid quantitation using LC-MS/MS [PDF]
A Tokumura +24 more
core +1 more source
Econazole Exhibits In Vitro and In Vivo Efficacy Against Leishmania amazonensis. [PDF]
Mesquita JT +3 more
europepmc +1 more source
Synthesis of a phosphocholine based lipid for improved micellar LC based in vitro predictions of human intestinal absorption and blood-brain barrier partitioning [PDF]
De Vrieze, Mike +4 more
core +1 more source
Bioactivity of miltefosine against aquatic stages of Schistosoma mansoni, Schistosoma haematobium and their snail hosts, supported by scanning electron microscopy [PDF]
Maha M Eissa +2 more
core +1 more source
Efficacy and safety of different drugs for the treatment of leishmaniasis: a systematic review and network meta-analysis. [PDF]
Fan Y +9 more
europepmc +1 more source
Evaluation of a Possible Synergistic Effect of Meglumine Antimoniate with Paromomycin, Miltefosine or Allopurinol on in Vitro Susceptibility of Leishmania tropica Resistant Isolate [PDF]
Background: Pentavalent antimonials are still the first choice treatment for leishmaniasis, but with low efficacy and resistance is emerging. In the present study, the effect of meglumine antimoniate (MA, Glucantime) combined with paromomycin ...
HAKIMI PARIZI, Maryam +4 more
core
Insights into drug resistance in <i>Leishmania</i>: Mechanisms, therapeutics, and clinical case studies. [PDF]
Ghousepeer GD +9 more
europepmc +1 more source
Multidrug-resistant Acanthamoeba keratitis caused by the T4 Genotype: A case report. [PDF]
Atighehchian M +4 more
europepmc +1 more source

